Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1964 Dec;43(12):2386–2393. doi: 10.1172/JCI105113

Cardiac Norepinephrine Stores in Experimental Heart Failure in the Dog*

Charles A Chidsey 1, Gerard A Kaiser 1, Edmund H Sonnenblick 1, James F Spann 1, Eugene Braunwald 1
PMCID: PMC289667  PMID: 14234835

Full text

PDF
2386

Images in this article

2387Image
on p.2387

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ANZOLA J., RUSHMER R. F. Cardiac responses to sympathetic stimulation. Circ Res. 1956 May;4(3):302–307. doi: 10.1161/01.res.4.3.302. [DOI] [PubMed] [Google Scholar]
  2. BARGER A. C., ROE B. B., RICHARDSON G. S. Relation of valvular lesions and of exercise to auricular pressure, work tolerance, and to development of chronic, congestive failure in dogs. Am J Physiol. 1952 May;169(2):384–399. doi: 10.1152/ajplegacy.1952.169.2.384. [DOI] [PubMed] [Google Scholar]
  3. BERTLER A., CARLSSON A., ROSENGREN E. A method for the fluorimetric determination of adrenaline and noradrenaline in tissues. Acta Physiol Scand. 1958 Dec 15;44(3-4):273–292. doi: 10.1111/j.1748-1716.1958.tb01627.x. [DOI] [PubMed] [Google Scholar]
  4. BRAUNWALD E., CHIDSEY C. A., HARRISON D. C., GAFFNEY T. E., KAHLER R. L. STUDIES ON THE FUNCTION OF THE ADRENERGIC NERVE ENDINGS IN THE HEART. Circulation. 1963 Nov;28:958–969. doi: 10.1161/01.cir.28.5.958. [DOI] [PubMed] [Google Scholar]
  5. BURCH G. E. Evidence for increased venous tone in chronic congestive heart failure. AMA Arch Intern Med. 1956 Dec;98(6):750–766. doi: 10.1001/archinte.1956.00250300068009. [DOI] [PubMed] [Google Scholar]
  6. BURCH G. E. Influence of the central nervous system on veins in man. Physiol Rev Suppl. 1960 Apr;4:50–56. [PubMed] [Google Scholar]
  7. BURN J. H., RAND M. J. The effect of precursors of noradrenalin on the response to tyramine and sympathetic stimulation. Br J Pharmacol Chemother. 1960 Mar;15:47–55. doi: 10.1111/j.1476-5381.1960.tb01209.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. CHIDSEY C. A., BRAUNWALD E., MORROW A. G., MASON D. T. MYOCARDIAL NOREPINEPHRINE CONCENTRATION IN MAN. EFFECTS OF RESERPINE AND OF CONGESTIVE HEART FAILURE. N Engl J Med. 1963 Sep 26;269:653–658. doi: 10.1056/NEJM196309262691302. [DOI] [PubMed] [Google Scholar]
  9. CHIDSEY C. A., HARRISON D. C., BRAUNWALD E. Augmentation of the plasma nor-epinephrine response to exercise in patients with congestive heart failure. N Engl J Med. 1962 Sep 27;267:650–654. doi: 10.1056/NEJM196209272671305. [DOI] [PubMed] [Google Scholar]
  10. COLEMAN B., GLAVIANO V. V. Tissue levels of norepinephrine and epinephrine in hemorrhagic shock. Science. 1963 Jan 4;139(3549):54–54. doi: 10.1126/science.139.3549.54. [DOI] [PubMed] [Google Scholar]
  11. CROUT J. R., CREVELING C. R., UDENFRIEND S. Norepinephrine metabolism in rat brain and heart. J Pharmacol Exp Ther. 1961 Jun;132:269–277. [PubMed] [Google Scholar]
  12. CROUT J. R., MUSKUS A. J., TRENDELENBURG U. Effect of tyramine on isolated guinea-pig atria in relation to their noradrenaline stores. Br J Pharmacol Chemother. 1962 Jun;18:600–611. doi: 10.1111/j.1476-5381.1962.tb01179.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. DAVIS J. O., HOWELL D. S. Mechanisms of fluid and electrolyte retention in experimental preparations in dogs. II. With thoracic inferior vena cava constriction. Circ Res. 1953 Mar;1(2):171–178. doi: 10.1161/01.res.1.2.171. [DOI] [PubMed] [Google Scholar]
  14. DAVIS J. O., TRAPASSO M., YANKOPOULOS N. A. Studies of actomyosin from cardiac muscle of dogs with experimental congestive heart failure. Circ Res. 1959 Nov;7:957–968. doi: 10.1161/01.res.7.6.957. [DOI] [PubMed] [Google Scholar]
  15. DAY M. D., RAND M. J. SOME OBSERVATIONS ON THE PHARMACOLOGY OF ALPHA-METHYLDOPA. Br J Pharmacol Chemother. 1964 Feb;22:72–86. doi: 10.1111/j.1476-5381.1964.tb01545.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. GAFFNEY T. E., CHIDSEY C. A., BRAUNWALD E. Study of the relationship between the neurotransmitter store and adrenergic nerve block induced by reserpine and guanethidine. Circ Res. 1963 Mar;12:264–268. doi: 10.1161/01.res.12.3.264. [DOI] [PubMed] [Google Scholar]
  17. GAFFNEY T. E., MORROW D. H., CHIDSEY C. A. The role of myocardial catecholamines in the response to tyramine. J Pharmacol Exp Ther. 1962 Sep;137:301–305. [PubMed] [Google Scholar]
  18. HIFT H., CAMPOS H. A. Changes in the subcellular distribution of cardiac catecholamines in dogs dying in irreversible haemorrhagic shock. Nature. 1962 Nov 17;196:678–679. doi: 10.1038/196678b0. [DOI] [PubMed] [Google Scholar]
  19. LEE W. C., SHIDEMAN F. E. Role of myocardial catecholamines in cardiac contractility. Science. 1959 Apr 10;129(3354):967–968. doi: 10.1126/science.129.3354.967. [DOI] [PubMed] [Google Scholar]
  20. LITTER J., WILKINS R. W., WOOD J. E. Peripheral venoconstriction in human congestive heart failure. Circulation. 1956 Apr;13(4):524–527. doi: 10.1161/01.cir.13.4.524. [DOI] [PubMed] [Google Scholar]
  21. Merrill A. J. EDEMA AND DECREASED RENAL BLOOD FLOW IN PATIENTS WITH CHRONIC CONGESTIVE HEART FAILURE: EVIDENCE OF "FORWARD FAILURE" AS THE PRIMARY CAUSE OF EDEMA. J Clin Invest. 1946 May;25(3):389–400. doi: 10.1172/JCI101720. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Myers J. D., Hickam J. B. AN ESTIMATION OF THE HEPATIC BLOOD FLOW AND SPLANCHNIC OXYGEN CONSUMPTION IN HEART FAILURE. J Clin Invest. 1948 Sep;27(5):620–627. doi: 10.1172/JCI102008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. SARNOFF S. J., BROCKMAN S. K., GILMORE J. P., LINDEN R. J., MITCHELL J. H. Regulation of ventricular contraction. Influence of cardiac sympathetic and vagal nerve stimulation on atrial and ventricular dynamics. Circ Res. 1960 Sep;8:1108–1122. doi: 10.1161/01.res.8.5.1108. [DOI] [PubMed] [Google Scholar]
  24. SONNENBLICK E. H. Force-velocity relations in mammalian heart muscle. Am J Physiol. 1962 May;202:931–939. doi: 10.1152/ajplegacy.1962.202.5.931. [DOI] [PubMed] [Google Scholar]
  25. SPANN J. F., Jr, CHIDSEY C. A., BRAUNWALD E. REDUCTION OF CARDIAC STORES OF NOREPINEPHRINE IN EXPERIMENTAL HEART FAILURE. Science. 1964 Sep 25;145(3639):1439–1441. doi: 10.1126/science.145.3639.1439-a. [DOI] [PubMed] [Google Scholar]
  26. TOMOMATSU T., UEBA Y., MATSUMOTO T., IKOMA T., KONDO Y. Catecholamine in congestive heart failure. I. Jpn Heart J. 1963 Jan;4:13–24. doi: 10.1536/ihj.4.13. [DOI] [PubMed] [Google Scholar]
  27. TRENDELENBURG U., GRAVENSTEIN J. S. Effect of reserpine pretreatment on stimulation of the accelerans nerve of the dog. Science. 1958 Oct 17;128(3329):901–903. doi: 10.1126/science.128.3329.901-a. [DOI] [PubMed] [Google Scholar]
  28. TRENDELENBURG U. Supersensitivity and subsensitivity to sympathomimetic amines. Pharmacol Rev. 1963 Jun;15:225–276. [PubMed] [Google Scholar]
  29. WOOD J. E. The mechanism of the increased venous pressure with exercise in congestive heart failure. J Clin Invest. 1962 Nov;41:2020–2024. doi: 10.1172/JCI104660. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. von EULER U., LISHAJKO F. Improved technique for the fluorimetric estimation of catecholamines. Acta Physiol Scand. 1961 Apr;51:348–355. doi: 10.1111/j.1748-1716.1961.tb02128.x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES